title: Acute myelogenous leukemia treated with daunomycin associated with nephrotic syndrome.
abstract: We report a 33-year-old patient with a diagnosis of acute myelogenous leukemia that developed a nephrotic syndrome 9 days after starting treatment with daunomycin. Pathological studies of the kidneys revealed minimal change disease with IgM deposits. Possible pathogenetic mechanisms are discussed.
authors.affiliation: Servicios de Medicina Interna, Nefrología y Anatomía Patológica, Fundación Jiménez Díaz, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Thomson
authors.forename: G
authors.initials: G
authors.lastname: de Arriba
authors.forename: J
authors.initials: J
authors.lastname: Ordi
authors.forename: H
authors.initials: H
authors.lastname: Oliva
authors.forename: L
authors.initials: L
authors.lastname: Hernando
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy*; D008297:Male; D009404:Nephrotic Syndrome / Q000209:etiology*
chemical_list: D003561:Cytarabine; D003630:Daunorubicin